Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease.
Saved in:
| Title: | Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease. |
|---|---|
| Authors: | Faldu KG; Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India., Shah JS; Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India. |
| Source: | Drug development research [Drug Dev Res] 2024 Nov; Vol. 85 (7), pp. e70017. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
